fingolimod hydrochloride has been researched along with Cardiac Remodeling, Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arias, T; Badimon, JJ; Fuster, V; Goliasch, G; Hajjar, RJ; Ishikawa, K; Narula, J; Njerve, IU; Picatoste, B; Santos-Gallego, CG; Sanz, J; Sengupta, PP; Vahl, TP | 1 |
| Altara, R; Booz, GW; Eid, A; Kaplan, A; Zouein, FA | 1 |
1 review(s) available for fingolimod hydrochloride and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Update on the Protective Role of Regulatory T Cells in Myocardial Infarction: A Promising Therapy to Repair the Heart.
Topics: Animals; CD28 Antigens; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Myocardial Infarction; Myocardial Reperfusion Injury; T-Lymphocytes, Regulatory; Ventricular Remodeling | 2016 |
1 other study(ies) available for fingolimod hydrochloride and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.
Topics: Animals; Disease Models, Animal; Fingolimod Hydrochloride; Myocardial Infarction; Myocardial Reperfusion Injury; Receptors, Lysosphingolipid; Salvage Therapy; Swine; Ventricular Remodeling | 2016 |